“…[32][33][34] More recently, radioimmunoconjugates, monoclonal antibodies against different antigens and molecule inhibitors, such as bruton tyrosine kinase inhibitors, have been added to the armamentarium of physicians treating NHL. 35 While the chances of a cure continue to improve with the advent of targeted therapy, parallel efforts are underway to reduce the short and long-term toxicity of these treatment options.…”